-Presenting at Citi Global and RBC Capital Markets Healthcare
Conferences-
-Participating in UBS Small/Mid-Cap Conference-
LEXINGTON, Mass.--(BUSINESS WIRE)--Feb. 16, 2012--
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the
Company will be presenting at the following upcoming investor
conferences:
Citi 2012 Global Healthcare Conference in New York
Monday, February
27 at 10:00 a.m. (ET)
RBC Capital Markets’ 2012 Healthcare Conference in New York
President
and CEO Safi Bahcall, Ph.D., will participate in a panel discussion
titled:
Unique, Later Stage Cancer Treatment Opportunities
Tuesday,
February 28 at 11:00 a.m. (ET)
A live audio webcast and replay of both the presentation and panel
discussion will be available on the "Investors" section of the Company's
website, www.syntapharma.com.
Synta will also be attending the UBS Securities Small/Mid-Cap Conference
in Boston, February 29, 2012. There is no formal presentation during the
UBS Conference, however management will be available for one-on-one
meetings during the conference.
About Synta Pharmaceuticals
Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on
discovering, developing, and commercializing small molecule drugs to
extend and enhance the lives of patients with severe medical conditions,
including cancer and chronic inflammatory diseases. Synta has a unique
chemical compound library, an integrated discovery engine, and a diverse
pipeline of clinical- and preclinical-stage drug candidates with
distinct mechanisms of action and novel chemical structures. All Synta
drug candidates were invented by Synta scientists using our compound
library and discovery capabilities. For more information, please visit www.syntapharma.com.
Source: Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp.
Rob Kloppenburg, 781-541-7125
